Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

240.69
+3.591.51%
Volume:1.64M
Turnover:393.46M
Market Cap:32.11B
PE:42.83
High:243.02
Open:235.94
Low:233.33
Close:237.10
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:1.03
T/O Rate:1.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:23.72
PE(LYR):103.30

Loading ...

Alnylam Pharmaceuticals Q1 Adj. EPS $1.99 Beats $0.93 Estimate, Sales $1.167B Beat $1.114B Estimate

Benzinga Earnings
·
Apr 30

Alnylam Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Period Progress

THOMSON REUTERS
·
Apr 30

Alnylam Pharmaceuticals Q1 Adjusted EPS USD 1.99 VS. Ibes Estimate USD 0.95

THOMSON REUTERS
·
Apr 30

Corrected-Alnylam Pharmaceuticals Q1 Net Product Revenue USD 1,036 Million

THOMSON REUTERS
·
Apr 30

Alnylam Pharmaceuticals Q1 Adjusted Operating Income USD 338.79 Million

THOMSON REUTERS
·
Apr 30

Alnylam Pharmaceuticals Inc: Reiterates 2026 Financial Guidance

THOMSON REUTERS
·
Apr 30

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 30

3 Stocks Estimated To Be Trading Below Intrinsic Value By Up To 35.4%

Simply Wall St.
·
Apr 30

H.C. Wainwright Remains a Buy on Alnylam Pharma (ALNY)

TIPRANKS
·
Apr 29

April 2026's Top 3 Stocks That May Be Trading Below Estimated Fair Value

Simply Wall St.
·
Apr 28

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-04-27

Reuters
·
Apr 27

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-04-24

Reuters
·
Apr 25

Earning Preview: Alnylam Pharmaceuticals revenue is expected to increase by 90.11%, and institutional views are broadly bullish

Earnings Agent
·
Apr 23

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-04-17

Reuters
·
Apr 18

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-04-16

Reuters
·
Apr 16

Alnylam schedules webcast conference call to discuss first-quarter results

Reuters
·
Apr 16

Alnylam Pharmaceuticals Inc : Leerink Partners Raises Target Price to $362 From $357

THOMSON REUTERS
·
Apr 16

U.S. RESEARCH ROUNDUP-CME Group, M&T Bank, PNC Financial Services

Reuters
·
Apr 16

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY) and Apellis Pharmaceuticals (APLS)

TIPRANKS
·
Apr 15

Alnylam Pharmaceuticals Is Maintained at Buy by Truist Securities

Dow Jones
·
Apr 14